NYSEAMERICAN : MYO
Myomo, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 1.24 USD (Oct 30, 2026, 10:15 AM EDT) · Market cap 49.11M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 49.11M |
| Enterprise Value | 55.74M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 39.61M |
| Shares Outstanding | 39.61M |
| Shares Change (YoY) | +4.64% |
| Shares Change (QoQ) | +2.51% |
| Owned by Insiders (%) | 7.70% |
| Owned by Institutions (%) | 22.84% |
| Float | 27.78M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.14 |
| Forward PS | 1.02 |
| PB Ratio | 8.41 |
| P/TBV Ratio | 11.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.31 |
| Quick Ratio | 1.73 |
| Debt / Equity | 3.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.54 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -123.76% |
| Return on Assets (ROA) | -19.76% |
| Return on Invested Capital (ROIC) | -26.14% |
| Return on Capital Employed (ROCE) | -47.32% |
| Weighted Average Cost of Capital (WACC) | 11.22% |
| Revenue Per Employee | $221,856 |
| Profits Per Employee | -$74,398 |
| Employee Count | 195 |
| Asset Turnover | 1.17 |
| Inventory Turnover | 3.75 |
Taxes
| Measure | Value |
|---|
| Income Tax | 437,655 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.58 |
| 52-Week Price Change | +28.48% |
| 50-Day Moving Average | 1.42 |
| 200-Day Moving Average | 1.08 |
| Relative Strength Index (RSI) | 42.83 |
| Average Volume (20 Days) | 238,033 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.06M |
| Short Previous Month | 1.20M |
| Short % of Shares Out | 2.69% |
| Short % of Float | 3.83% |
| Short Ratio (days to cover) | 3.12 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 43.26M |
| Gross Profit | 29.57M |
| Operating Income | -11.70M |
| Pretax Income | -14.07M |
| Net Income | -14.51M |
| EBITDA | -10.52M |
| EBIT | -11.70M |
| Loss Per Share | -$0.37 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 13.45M |
| Total Debt | 20.08M |
| Net Cash | -6.63M |
| Net Cash Per Share | -$0.17 |
| Equity (Book Value) | 5.83M |
| Book Value Per Share | 0.15 |
| Working Capital | 13.92M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -7.11M |
| Capital Expenditures | -1.21M |
| Depreciation & Amortization | 1.19M |
| Net Borrowing | 8.50M |
| Free Cash Flow | -8.32M |
| FCF Per Share | -$0.21 |
Margins
| Measure | Value |
|---|
| Gross Margin | 68.35% |
| Operating Margin | -27.05% |
| Pretax Margin | -32.52% |
| Profit Margin | -33.53% |
| EBITDA Margin | -24.31% |
| EBIT Margin | -27.05% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -4.64% |
| Shareholder Yield | -4.64% |
| Earnings Yield | -29.59% |
| FCF Yield | -16.94% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $4.64 |
| Price Target Difference | 274.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 16.12% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jan 31, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -3.57 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |